Extension of Baycol class action

US and German lawyers are seeking to include claimants from more than 50 countries worldwide in the class action suit relating to cholesterol drug Baycol (marketed as Lipobay outside the US). Papers will be filed in the US District Court, Minnesota. Bayer is opposing this – US awards are likely to be higher than elsewhere and include punitive damages. Bayer has expressed confidence that the court would reject the move, particularly in relation to German claims.